Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

Jan. 5, 1998

New anticoagulants reported by Berlex

Jan. 2, 1998

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

Improved method for vWF purification developed by Bayer

Dec. 31, 1997

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Dec. 29, 1997

Tanabe Seiyaku claims new PAI-1 inhibitors

Dec. 24, 1997

FDA issues health advisory for anticoagulants

Dec. 18, 1997

Promising results reported from rhATIII trial

Dec. 18, 1997

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...